We had solved that single molecule signal ... landmark NGS papers in November 2008—the first African genome, the first Asian genome, and the first cancer genome—all featuring the Illumina ...

This is why we partnered with Illumina, the leading NGS provider, integrating our DNA ... grew double digits year-over-year, a strong signal of a broadening adoption. As we roll out additional ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.

which is expected to directly compete with Illumina’s next-generation sequencing (NGS) portfolio. Roche’s management has expressed confidence that SBX can produce data comparable to NGS ...

which is expected to directly compete with Illumina’s next-generation sequencing (NGS) portfolio. Roche’s management has expressed confidence that SBX can produce data comparable to NGS, while also ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

The ‘omics’ field has advanced spectacularly since then, fueled by the advent of next-generation sequencing (NGS ... by the summit sponsors – Illumina, Sampled, Scale Biosciences, and ...

11 analysts have expressed a variety of opinions on Illumina ILMN over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...